Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (10): 1134-1137.doi: 10.3969/j.issn.1000-6621.2018.10.019
• Review Articles • Previous Articles Next Articles
Ze-cheng CAI1,He MA1,Zhao-hui GE2,()
Received:
2018-06-06
Online:
2018-10-10
Published:
2018-10-18
Contact:
Zhao-hui GE
E-mail:myovid@126.com
Ze-cheng CAI,He MA,Zhao-hui GE. The progress of establishing animal model of spinal tuberculosis[J]. Chinese Journal of Antituberculosis, 2018, 40(10): 1134-1137. doi: 10.3969/j.issn.1000-6621.2018.10.019
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.10.019
[1] | World Health Organization . Global tuberculosis report 2017. Geneva: World Health Organization, 2017. |
[2] | Chen ST, Zhao LP, Dong WJ , et al. The clinical features and bacteriological characterizations of bone and joint tuberculosis in China. Sci Rep, 2015,5:11084. |
[3] | Huang D, Li D, Wang T , et al. Isoniazid conjugated poly (lactide-co-glycolide): long-term controlled drug release and tissue regeneration for bone tuberculosis therapy. Biomaterials, 2015,52:417-425. |
[4] |
Liu P, Fu Z, Jiang J , et al. Determination of isoniazid concentration in rabbit vertebrae by isotope tracing technique in conjunction with HPLC. Biomed Chromatogr, 2013,27(9):1150-1156.
doi: 10.1002/bmc.2920 |
[5] | Carrillo C, Wigdorovitz A, Trono K , et al. Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants. Viral Immunol, 2001,14(1):49-57. |
[6] | Ghodbane R, Raoult D, Drancourt M . Dramatic reduction of culture time of Mycobacterium tuberculosis. Sci Rep, 2014,4:4236. |
[7] |
林旭 . 缓释利福平微球释药性质及兔脊柱结核模型建立的初步实验研究. 成都:四川大学, 2006.
doi: 10.7666/d.y995200 URL |
[8] |
苏明权, 张建芳, 苏哲 , 等. 一种新型结核杆菌快速培养促生长剂的研制. 中国人兽共患病学报, 2006,22(11):1062-1064.
doi: 10.3969/j.issn.1002-2694.2006.11.015 URL |
[9] | Guo XH, Bai Z, Qiang B , et al. Roles of monocyte chemotactic protein 1 and nuclear factor-κB in immune response to spinal tuberculosis in a New Zealand white rabbit model. Braz J Med Biol Res, 2017,50(3):e5625. |
[10] | 乔永杰, 李松凯, 甄平 , 等. 不同浓度结核菌建立兔脊柱结核模型的对比研究. 中国矫形外科杂志, 2017,25(5):459-465. |
[11] |
陈领, 贾赤宇 . 结核性创面动物模型研究进展. 中华烧伤杂志, 2015,31(6):436-438.
doi: 10.3760/cma.j.issn.1009-2587.2015.06.012 URL |
[12] | Wang XW, Liu JJ, Wu QN , et al. The in vitro and in vivo effects of microRNA-133a on intervertebral disc destruction by targeting MMP9 in spinal tuberculosis. Life Sci, 2017,188:198-205. |
[13] | Smith DW, Harding GE . Animal model of human disease. Pulmonary tuberculosis. Animal model: Experimental airborne tuberculosis in the guinea pig. Am J Pathol, 1977,89(1):273-276. |
[14] |
Orme IM, Ordway DJ . Mouse and guinea pig models of tuberculosis. Microbiol Spectr, 2016,4(4).
doi: 10.1128/microbiolspec.TBTB2-0002-2015 URL pmid: 27726797 |
[15] | Dharmadhikari AS, Nardell EA . What animal models teach humans about tuberculosis. Am J Respir Cell Mol Biol, 2008,39(5):503-508. |
[16] | Dutta NK, Illei PB, Jain SK , et al. Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice. Am J Pathol, 2014,184(7):2045-2055. |
[17] | Bai X, Shang S, Henao-Tamayo M , et al. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A, 2015,112(16):5111-5116. |
[18] | Jasenosky LD, Scriba TJ, Hanekom WA , et al. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev, 2015,264(1):74-87. |
[19] |
Acosta A, Norazmi MN, Hernandez-Pando R , et al. The importance of animal models in tuberculosis vaccine development. Malays J Med Sci, 2011,18(4):5-12.
URL pmid: 22589668 |
[20] | 高琪乐, 张宏其, 郭超峰 , 等. 小鼠脊柱结核模型的构建及椎体骨密度改变的初步研究. 中国矫形外科杂志, 2018,26(2):155-158. |
[21] | Subbian S, Tsenova L , O’Brien P, et al. Spontaneous latency in a rabbit model of pulmonary tuberculosis. Am J Pathol, 2012,181(5):1711-1724. |
[22] | Manabe YC, Dannenberg AM Jr, Tyagi SK , et al. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect Immun, 2003,71(10):6004-6011. |
[23] |
Dannenberg AM Jr . Perspectives on clinical and preclinical testing of new tuberculosis vaccines. Clin Microbiol Rev, 2010,23(4):781-794.
doi: 10.1128/CMR.00005-10 URL pmid: 2952977 |
[24] |
陈振, 吴鹏, 马荣 , 等. 构建新西兰兔脊柱结核模型的实验研究. 宁夏医科大学学报, 2015,37(10):216-223.
doi: 10.16050/j.cnki.issn1674-6309.2015.10.003 URL |
[25] |
Flynn JL, Gideon HP, Mattila JT , et al. Immunology studies in non-human primate models of tuberculosis. Immunol Rev, 2015,264(1):60-73.
doi: 10.1111/imr.12258 URL pmid: 25703552 |
[26] |
Peña JC, Ho WZ . Non-human primate models of tuberculosis. Microbiol Spectr, 2016,4(4).
doi: 10.1128/microbiolspec.TBTB2-0007-2016 URL pmid: 27726820 |
[27] | Sharpe S, White A, Gleeson F , et al. Ultra low dose aerosol challenge with Mycobacterium tuberculosis leads to divergent outcomes in rhesus and cynomolgus macaques. Tuberculosis (Edinb), 2016,96:1-12. |
[28] | Orr MT, Fox CB, Baldwin SL , et al. Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis. J Control Release, 2013,172(1):190-200. |
[29] | Lindberg L . A method for producing experimental skeletal tuberculosis in bone marrow necrosis in the guineapig. Acta Pathol Microbiol Scand, 1968,72(4):575-585. |
[30] | 吴启秋, 段连山, 梁桂芳 , 等. 兔膝关节结核模型的建立及其应用. 结核病与胸部肿瘤, 2002, ( 3):174-176. |
[31] | Liu P, Jiang H, Li S , et al. Determination of anti-tuberculosis drug concentration and distribution from sustained release microspheres in the vertebrae of a spinal tuberculosis rabbit model. J Orthop Res, 2017,35(1):200-208. |
[32] |
Geng G, Wang Q, Shi J , et al. Establishment of a New Zea-land rabbit model of spinal tuberculosis. J Spinal Disord Tech, 2015,28(3):E140-145.
doi: 10.1097/BSD.0000000000000191 URL pmid: 25325713 |
[33] |
王非, 瞿东滨, 金大地 . 侧方入路显露兔腰椎间盘及椎间盘内的注射方法. 中华实验外科杂志, 2003,20(3):204.
doi: 10.3760/j.issn:1001-9030.2003.03.039 URL |
[34] |
王云玲, 刘莹, 王红 , 等. 建立新西兰白兔脊柱结核的两种方法比较研究. 新疆医学, 2012,42(6):1-4.
doi: 10.3969/j.issn.1001-5183.2012.06.001 URL |
[35] |
Geng G, Wang Q, Wang Z , et al. Comparative study of the spinal tuberculosis model with the New Zealand rabbit. Chin J Orthop, 2014,34(2):216-223.
doi: 10.3760/cma.j.issn.0253-2352.2014.02.019 URL |
[36] | Liu XC, Jia WX, Wang H , et al. Applications of diffusion-weighted mr imaging in rabbits mode of spinal tuberculosis. Chin Comp Med, 2014,20(2):182-186. |
[37] | Liu X, Jia W, Wang H , et al. Establishment of a rabbit model of spinal tuberculosis using Mycobacterium tuberculosis strain H37Rv. Jpn J Infect Dis, 2015,68(2):89-97. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||